Louis Chen
Stock Analyst at Cantor Fitzgerald
(n/a)
# 4,972
Out of 4,975 analysts
11
Total ratings
10%
Success rate
-55.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $3.46 | - | 8 | Sep 10, 2024 | |
| THTX Theratechnologies | Reiterates: Overweight | $36 | $3.27 | +1,000.92% | 2 | Jul 13, 2023 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $33.03 | +66.52% | 1 | Feb 24, 2022 |
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $3.46
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $3.27
Upside: +1,000.92%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $33.03
Upside: +66.52%